Drug details

Belviq XR (lorcaserin hydrochloride extended release tablets)

type of CNS Stimulants, Anorexiants

Belviq XR (lorcaserin hydrochloride) extended-release tablets is a serotonin 2C receptor agonist indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition, (e.g., hypertension, dyslipidemia, type 2 diabetes).

The drug is often used to treat Type 2 diabetes .

This drug may have the following side effects:

• headache
• cough
• nausea
• diarrhea
• vomiting
• dizziness
• fatigue
• constipation
• rash
• upper respiratory tract infection
• muscle pain
• back pain
• dry mouth
• stuffy nose, and
• urinary tract infection
• common cold
• mouth and throat pain

The following drugs are related to Belviq XR, either as a replacement or used together:

• Adipex-P (phentermine hydrochloride)
• Belviq (lorcaserin hydrochloride)
• Didrex (benzphetamine)
• Bontril PDM (phendimetrazine tartrate tablets)
• Bontril SR (phendimetrazine tartrate slow release capsules)
• Contrave (naltrexone hcl and bupropion hcl extended-release tablets)
• Desoxyn (methamphetamine hydrochloride)
• Synthroid (levothyroxine sodium)
• Meridia (sibutramine hydrochloride monohydrate)
• Xenical (orlistat 120 mg)
• Qsymia (phentermine and topiramate)
• Suprenza (phentermine hydrochloride)
• Plenity (superabsorbent hydrogel particles in capsules)